Manisha Samy, ARK Analyst. She joined ARK as a thematic analyst on the Genomic Revolution team in February 2016. Her focus is on Instrumentation, Targeted Therapeutics, Agricultural Biology, Diagnostics and Stem Cells. Prior to ARK, Manisha worked as a management consultant for Kepler Cannon. Before that, she gained experience as a business solution analyst at Attensity America. Manisha graduated from Stanford with a Bachelor of Science in Science, Technology, and Society: Life Sciences and Biotechnology.